Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
5,928,539
-
Share change
-
+400,426
-
Total reported value
-
$37,972,000
-
Price per share
-
$6.41
-
Number of holders
-
28
-
Value change
-
+$2,591,136
-
Number of buys
-
13
-
Number of sells
-
9
Institutional Holders of AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) as of Q3 2016
As of 30 Sep 2016,
AEGLEA BIOTHERAPEUTICS INC - COM (AGLE) was held by
28 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
5,928,539 shares.
The largest 10 holders included
JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, UNIVERSITY OF TEXAS INVESTMENT MANAGMENT CO, Rock Springs Capital Management LP, BAKER BROS. ADVISORS LP, DAFNA Capital Management LLC, VHCP Management II, LLC, RA CAPITAL MANAGEMENT, LLC, Sio Capital Management, LLC, and Alyeska Investment Group, L.P..
This page lists
28
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.